FdaApplication
BLA 761055
Identifiers
- fda_app_no: BLA761055
Properties
| Property | Value |
|---|---|
| applicant_name | Regeneron Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2017-03-28 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DUPIXENT | DUPILUMAB | 300MG/2ML | INJECTABLE;INJECTION |
| DUPIXENT | — | 200MG/1.14ML | Injection |
| DUPIXENT | — | 100MG/0.67ML | Injection |
| DUPIXENT | — | 300MG/2ML | Injection |
| DUPIXENT | — | 300MG/2ML | Injection |
| DUPIXENT | — | 200MG/1.14ML | Injection |
6 products